FDA willing to fast track coronavirus vaccine before phase three trials

The chief of the U.S. Food and Drug Administration told the Financial Times that he is willing to bypass the standard approval process in order to make a Covid-19 vaccine available as soon as possible.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.